Crossref
First approved drug for mitochondrial disease raises hopes for more
Science · 2025
DOI: 10.1126/science.aec9018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2025. Verfasst von Mitch Leslie. Hauptthemen laut MEDLINE: Drug Approval, Mitochondrial Diseases, Rare Diseases.
Abstract (Originalsprache)
Researchers are testing multiple treatments for the rare genetic conditions
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Drug ApprovalMitochondrial DiseasesRare DiseasesHumansUnited StatesUnited States Food and Drug AdministrationThymidine Kinase
Substanzen
thymidine kinase 2Thymidine Kinase
Zitieren
APA
Leslie, M. (2025). First approved drug for mitochondrial disease raises hopes for more. Science. https://doi.org/10.1126/science.aec9018
Vancouver
Leslie M. First approved drug for mitochondrial disease raises hopes for more. Science. 2025. doi:10.1126/science.aec9018
BibTeX
@article{Leslie2025,
author = {Leslie, Mitch},
title = {First approved drug for mitochondrial disease raises hopes for more},
journal = {Science},
year = {2025},
doi = {10.1126/science.aec9018}
}
EUVIMED